Pfizer expects revenue to drop by as much as a third in 2023 and then rebound in 2024 thanks to the new combo flu-Covid19 vaccine development and approval. “The assumption is that Covid will not disappear” said CEO #Bourla. https://www.wsj.com/articles/pfizer-pfe-4q-earnings-report-2023-11675168771

🐦🔗: https://n.respublicae.eu/ladyonorato/status/1638565371014725632